s6y
Company name or ticker
Search
Neumora Therapeutics, Inc.
POSASR
Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
Filed
Monday, March 3, 2025
Accession number
0001193125-25-043400
Documents
POSASR
POSASR
EX-5.1
EX-5.1
EX-23.2
EX-23.2
EX-FILING FEES
EX-FILING FEES
On sec.gov
Filing index
All files
Complete submission text
SGML header